טוען...
Desmopressin administration to reduce rebleeding in Subarachnoid Hemorrhage: analysis of an observational prospective database
OBJECTIVE: Rebleeding remains a frequent and catastrophic event leading to poor outcome after subarachnoid hemorrhage (SAH). Reduced platelet function after the initial bleed is associated with higher risk of early rebleeding. Desmopressin (DDAVP) is a well known hemostatic agent and recent guidelin...
שמור ב:
| הוצא לאור ב: | J Neurosurg |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6688966/ https://ncbi.nlm.nih.gov/pubmed/29393750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2017.7.JNS17990 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|